【24h】

Gene Selection and Classification of Human Lymphoma from Microarray Data

机译:基因芯片对人类淋巴瘤的基因选择和分类

获取原文
获取原文并翻译 | 示例

摘要

Experiments in DNA microarray provide information of thousands of genes, and bioinformatics researchers have analyzed them with various machine learning techniques to diagnose diseases. Recently Support Vector Machines (SVM) have been demonstrated as an effective tool in analyzing microarray data. Previous work involving SVM used every gene in the microarray to classify normal and malignant lymphoid tissue. This paper shows that, using gene selection techniques that selected only 10% of the genes in "Lymphochip" (a DNA microarray developed at Stanford University School of Medicine), a classification accuracy of about 98% is achieved which is a comparable performance to using every gene. This paper thus demonstrates the usefulness of feature selection techniques in conjunction with SVM to improve its performance in analyzing Lymphochip microarray data. The improved performance was evident in terms of better accuracy, ROC (receiver operating characteristics) analysis and faster training. Using the subsets of Lymphochip, this paper then compared the performance of SVM against two other well-known classifiers: multi-layer perceptron (MLP) and linear discriminant analysis (LDA). Experimental results show that SVM outperforms the other two classifiers.
机译:DNA微阵列中的实验可提供数千种基因的信息,生物信息学研究人员已通过各种机器学习技术对它们进行了分析以诊断疾病。最近,已经证明了支持向量机(SVM)作为分析微阵列数据的有效工具。先前涉及SVM的工作使用微阵列中的每个基因对正常和恶性淋巴组织进行分类。本文显示,使用仅选择“ Lymphochip”(斯坦福大学医学院开发的DNA微阵列)中10%基因的基因选择技术,可以实现约98%的分类准确度,与使用每个基因。因此,本文证明了与SVM结合使用的特征选择技术可提高其在分析Lymphochip微阵列数据中的性能。从更好的准确性,ROC(接收机工作特性)分析和更快的培训方面来看,性能的提高是显而易见的。然后,使用Lymphochip的子集,将SVM的性能与其他两个著名的分类器进行了比较:多层感知器(MLP)和线性判别分析(LDA)。实验结果表明,SVM优于其他两个分类器。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号